Onconome Home  
Home Our Company Our Technology Our Pipeline Collaborations Contact

Prostate Cancer

There is an enormous global, unmet need for effective serum and tissue tests to detect prostate cancer early.

Prostate Cancer Facts:

  Prostate cancer is the most common malignant cancer and the second leading cause of cancer-related death in American men

  If detected early, patients with aggressive forms of prostate cancer can be treated before it metastasizes and migrates to the lymph glands or to bone; undetected it can be deadly

  If non-aggressive forms of prostate cancer are mistakenly identified as malignant, unnecessary surgical intervention or other invasive therapies may be used, which are expensive, potentially life-altering and may lead to serious complications

  Current detection methods have severe limitations: (a) Digital Rectal Exam... inconclusive results, even in high risk men; (b) PSA... 80% false positives and 20% false negatives; (c) Biopsies... accurate only if the biopsy needle actually hits a tumor, which it often fails to do


Learn about our EIA and IHC Test for prostate cancer
 
 
   
 
 
   
 
 
   
 
 
Related Links:
   
photo

 
Onconome:
Home | Our Technology | Our Products | Our Company | Collaborations | Contact
Copyright © 2002-2008 Onconome, Inc. All rights reserved | Privacy